DNA REPAIR DISORDER

Clinical trials for DNA REPAIR DISORDER explained in plain language.

Never miss a new study

Get alerted when new DNA REPAIR DISORDER trials appear

Sign up with your email to follow new studies for DNA REPAIR DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Immunotherapy combo aims to prevent colon cancer return in High-Risk patients

Disease control Ongoing

This phase 3 trial is testing whether adding the immunotherapy drug atezolizumab to standard chemotherapy can help prevent cancer from coming back in people with stage III colon cancer that has a specific DNA repair defect (dMMR). About 712 participants will receive either chemo …

Matched conditions: DNA REPAIR DISORDER

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jul 02, 2026 07:00 UTC

DNA REPAIR DISORDER

Get alerted when new DNA REPAIR DISORDER trials appear

Immunotherapy combo aims to prevent colon cancer return in High-Risk patients